Bessemer Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,229
Closed -$63K 1818
2017
Q4
$63K Sell
2,229
-6,100
-73% -$172K ﹤0.01% 1222
2017
Q3
$259K Buy
8,329
+6,100
+274% +$190K ﹤0.01% 1005
2017
Q2
$71K Sell
2,229
-15,172
-87% -$483K ﹤0.01% 1245
2017
Q1
$394K Hold
17,401
﹤0.01% 934
2016
Q4
$380K Buy
+17,401
New +$380K ﹤0.01% 950